Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Placebo Controlled Study of the Efficacy and Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain Injury

NCT00375869 is registered in ClinicalTrials.gov with Royal Alexandra Hospital as lead sponsor.

NCT NCT00375869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00375869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Placebo Controlled Study of the Efficacy and Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain Injury
Lead sponsor
Royal Alexandra Hospital
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2006
Completion date
December 31, 2009
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury